220 related articles for article (PubMed ID: 28457398)
1. Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study.
Rodrigues N; Santana A; Guerra J; Neves M; Nascimento C; Gonçalves J; da Costa AG
Transplant Proc; 2017 May; 49(4):799-802. PubMed ID: 28457398
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus-associated hypomagnesemia in renal transplant recipients.
Navaneethan SD; Sankarasubbaiyan S; Gross MD; Jeevanantham V; Monk RD
Transplant Proc; 2006 Jun; 38(5):1320-2. PubMed ID: 16797291
[TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia in Pediatric Heart Transplant Patients Treated with Tacrolimus.
Erdogan I; Gursu HA; Varan B; Ozkan M; Sezgin A
Exp Clin Transplant; 2018 Oct; 16(5):592-595. PubMed ID: 27364480
[TBL] [Abstract][Full Text] [Related]
4. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
5. Magnesium excretion and hypomagnesemia in pediatric renal transplant recipients.
Uslu Gökceoğlu A; Comak E; Dogan CS; Koyun M; Akbas H; Akman S
Ren Fail; 2014 Aug; 36(7):1056-9. PubMed ID: 24828469
[TBL] [Abstract][Full Text] [Related]
6. Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors.
Niel OR; Berthoux F; Albano L; Dahan P; Aoudia R; Gugenheim J; Cassuto E
Transplant Proc; 2009 Oct; 41(8):3329-32. PubMed ID: 19857743
[TBL] [Abstract][Full Text] [Related]
7. The effect of maintenance immunosuppression medication on the change in kidney allograft function.
Gill JS; Tonelli M; Mix CH; Johnson N; Pereira BJ
Kidney Int; 2004 Feb; 65(2):692-9. PubMed ID: 14717943
[TBL] [Abstract][Full Text] [Related]
8. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.
Sabbagh F; El Tawil Z; Lecerf F; Hulin A; Maurois P; Dartevelle P; Bac P; German-Fattal M
Transplantation; 2008 Aug; 86(3):436-44. PubMed ID: 18698248
[TBL] [Abstract][Full Text] [Related]
9. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
Karie-Guigues S; Janus N; Saliba F; Dumortier J; Duvoux C; Calmus Y; Lorho R; Deray G; Launay-Vacher V; Pageaux GP
Liver Transpl; 2009 Sep; 15(9):1083-91. PubMed ID: 19718632
[TBL] [Abstract][Full Text] [Related]
10. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients.
Nawaz SH; Zafar MN; Naqvi SA; Rizvi SA
J Pak Med Assoc; 2005 Mar; 55(3):98-100. PubMed ID: 15852743
[TBL] [Abstract][Full Text] [Related]
11. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant.
Kahvecioglu S; Ersoy A; Gullulu M; Dirican M
Exp Clin Transplant; 2014 Aug; 12(4):334-42. PubMed ID: 24447269
[TBL] [Abstract][Full Text] [Related]
12. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.
Weir MR; Pearson TC; Patel A; Peddi VR; Kalil R; Scandling J; Chan L; Baliga P; Melton L; Mulgaonkar S; Waid T; Schaefer H; Youssef N; Anandagoda L; McCollum D; Lawson S; Gordon R
Transplantation; 2017 Jan; 101(1):157-165. PubMed ID: 26950714
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.
Ledeganck KJ; Anné C; De Monie A; Meybosch S; Verpooten GA; Vinckx M; Van Hoeck K; Van Eyck A; De Winter BY; Trouet D
Nutrients; 2018 May; 10(6):. PubMed ID: 29861470
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine and tacrolimus: influence on cardiovascular risk factors.
Hohage H; Hillebrandt U; Welling U; Zeh M; Heck M; Gerhardt UW; Suwelack BM
Transplant Proc; 2005 Mar; 37(2):1036-8. PubMed ID: 15848615
[TBL] [Abstract][Full Text] [Related]
17. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
18. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
[TBL] [Abstract][Full Text] [Related]
19. [Magnesium deficiency after kidney transplantation and cyclosporine therapy].
Rob PM
Fortschr Med; 1996 Apr; 114(10):125-6. PubMed ID: 8655118
[No Abstract] [Full Text] [Related]
20. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.
Van Ende C; Van Laecke S; Marechal C; Verbeke F; Kanaan N; Goffin E; Vanholder R; Jadoul M
J Nephrol; 2014 Dec; 27(6):707-11. PubMed ID: 24816563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
